🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

CMS offers two-year transition for Part D plans for safe harbor rule modernhealthcare.com/government/cms… via Modern Healthcare

SmithRx publicly supports HHS proposal to end rebates businesswire.com/news/home/2019…

We commend Chairman Grassley and Ranking Member Wyden for shining the spotlight on the business practices of the traditional #PBMs at today’s hearing. Read more about our solution at fiercehealthcare.com/payer/industry…

Great article by Jack O’Brien yesterday about the PBM Senate Finance Committee hearing - Blame Game, Again: PBM Execs Jockey With Senators Over Price Transparency shar.es/am9WUo

On Monday Jake Frenz spoke on a panel at the Milken Institute Global Conference about how veterans, companies and communities can approach the problems and opportunities that arise for the 200,000-plus veterans leaving active-duty service each year.

"the only way to generate true price competition is to make it clear to all parties how much drugs really cost." - CEO, Jake Frenz in today's HealthLeaders story: shar.es/a0FL9Y

Our very own Dustin Conrad will be speaking at the ISCEBS Symposium in New Orleans tomorrow at 2:45pm! He will be joined by Elizabeth Sennett and Dean Martin about the benefits of a pass-through PBM model. Let us know if you are going to be there and want to chat!

A busy day for SmithRx - Jake Frenz is joining the first of the EHIR (Employer Health Innovation Roundtable) Fall panel discussions and Dustin Conrad is presenting at the ISCEBS Symposium!

Check out our CEO Jake Frenz in the September issue of @1stRManagedCare! tinyurl.com/y4ns2nlx

The average cost of employer health coverage passed $20,000 for a family plan this year, a Kaiser survey found, as health care resonates politically wsj.com/articles/cost-… via The Wall Street Journal

We're teaming up with Mark Cuban Cost Plus Drug Company to make prescription drugs more affordable! Starting April, SmithRx members will be able to fill prescriptions at Mark Cuban Cost Plus Drugs. Two companies / one mission: fair drug prices! smithrx.com/blog/smithrx-a…

Gov't taking steps to protect Americans from predatory PBMs. That's good. But it could take a while for the gov't to fix this. In the meantime, take matters into your own hands: protect yourself by working with a 100% pass-through PBM like SmithRx. endpts.com/ohio-attorney-…

Drug manufacturer: this drug is available for $85k/year or $40k/year, the PBM can choose. The two versions are the exact same drug. Legacy PBMs: we'll take the more expensive one, please. 🤔 smithrx.com/blog/same-drug…

To lower drug prices for patients, Congress must comprehensively reform the middlemen of drug pricing – PBMs. Piecemeal legislation, even if strong, will just squeeze the balloon, instead of popping the gross-to-net bubble.

Pretty stunning that SmithRx is offering Yusimry as a Humira alternative saving thousands of dollars per patient able to make news doing it when this is so obviously good for patients.

📢 We now carry Brenzavvy™ (bexagliflozin) on costplusdrugs.com thanks to TheracosBio! costplusdrugs.com/medications/br… A 30-day supply of the newest SGLT2 inhibitor on the market is available for $47.85 + shipping. Visit brenzavvy.com for full details on the